FKBP5 rs1360787: Genetic Variation and Stress Sensitivity
The rs1360787 variant is a single-nucleotide polymorphism located in the FKBP5 gene on chromosome 6. It functions as a regulatory variant linked to the molecular regulation of the glucocorticoid receptor complex and hypothalamic-pituitary-adrenal axis signaling. Published research associates this variant with subtle shifts in stress hormone regulation and altered susceptibility to stress-related neuropsychiatric outcomes, though evidence is limited and strongly influenced by environmental factors.
What each genotype means
Typical stress response profile
This genotype is considered the major allele in many populations. Research suggests individuals with this profile typically exhibit standard glucocorticoid receptor sensitivity and HPA axis regulation, though individual stress responses are influenced by many genetic and environmental factors.
This is the most common genotype in many global populations, particularly in those of European ancestry.
Intermediate stress response profile
Carrying one copy of the minor allele may result in intermediate FKBP5 protein expression levels compared to homozygotes. Studies on FKBP5 variants suggest potential differences in how the body regulates stress hormones, but findings remain inconsistent regarding clinical outcomes like depression or treatment response.
This heterozygous genotype is found in a significant portion of the population, reflecting the common nature of the T allele.
Altered stress response profile
This genotype is associated with increased FKBP5 protein expression, which can influence the feedback loop of the stress hormone system. While some research links this variant to differences in cortisol regulation and potential susceptibility to stress-related outcomes, the evidence is mixed and should not be used to predict specific health conditions. Please discuss any concerns regarding stress or medication response with your healthcare provider.
This genotype is less common than the CC or CT genotypes, appearing in approximately 10-30% of individuals depending on ancestral background.
What Is rs1360787 and Where Is It Located?
The single-nucleotide polymorphism rs1360787 is a non-coding variant situated within the human FKBP5 gene on chromosome 6p21.31. Variants across this genomic locus typically occur in regulatory regions, such as introns, where they can influence transcriptional efficiency, chromatin architecture, or responsiveness to cellular signals rather than directly altering the amino acid sequence of the protein. The FKBP5 locus contains several single-nucleotide polymorphisms that are frequently inherited together in distinct haplotypes across human populations. Because rs1360787 is located in a regulatory section of the gene, researchers have focused on how its presence might modify transcription factor binding and the overall induction of the gene's messenger RNA in response to physiological stress. In genomic reference catalogs such as dbSNP, rs1360787 represents a common biallelic variation. While not a direct coding mutation that disrupts protein structure, changes in these non-coding regulatory sequences can modulate how dynamically the surrounding gene responds to fluctuating physiological conditions.
Biological Role of FKBP5 in Stress Physiology
The FKBP5 gene encodes the FK506-binding protein 51 (FKBP51), an immunophilin co-chaperone that plays a pivotal role in the human stress response. FKBP51 interacts directly with heat shock protein 90 (Hsp90) and the glucocorticoid receptor (GR) in the cytoplasm. When FKBP51 is bound within this chaperone heterocomplex, the receptor exhibits lower binding affinity for cortisol and other glucocorticoids, effectively delaying its nuclear translocation and transcriptional activity. Once glucocorticoids activate the pathway, FKBP5 transcription is naturally induced as part of an ultra-short intracellular negative feedback loop, which acts to attenuate excessive glucocorticoid signaling. Proper calibration of this feedback loop is necessary for the normal functioning of the hypothalamic-pituitary-adrenal (HPA) axis. When regulatory variations perturb the baseline or induced levels of FKBP51 expression, the sensitivity of the glucocorticoid receptor shifts. This can reduce the efficiency of negative feedback, prolong circulating cortisol elevation, and alter how neural circuits adapt to environmental stressors.
Scientific Evidence and Neuropsychiatric Associations
Published candidate-gene studies and neuropsychiatric research have investigated variations across the FKBP5 locus—including rs1360787 and closely linked variants—for associations with conditions such as major depressive disorder, post-traumatic stress disorder (PTSD), and altered stress reactivity. According to curated catalogs, the overall evidence strength for rs1360787 as an independent diagnostic predictor remains limited. Many genetic studies in this field highlight a gene-environment interaction (GxE) framework: specific alleles often do not confer elevated risk on their own, but rather demonstrate altered vulnerability or resilience in individuals exposed to significant early-life adversity or chronic trauma. Furthermore, findings across large genome-wide association studies (GWAS) have yielded mixed or modest effect sizes when examining unstratified populations, underscoring that FKBP5 variation does not act deterministically. Instead, it serves as one subtle component in a polygenic and highly environmentally mediated network governing psychological and neuroendocrine stress responses.
Understanding Ancestry and Population Frequencies
Allele frequencies for FKBP5 polymorphisms show notable variation across ancestral backgrounds. For rs1360787, genomic databases and catalog records indicate a minor allele frequency of approximately 0.30 in populations of European ancestry. In contrast, the minor allele frequency is noticeably lower in East Asian populations, observed at approximately 0.10. These differences in baseline allele frequencies mean that the distribution of homozygous and heterozygous genotypes differs widely between global populations. Understanding these frequency differences is essential in genetic research, as associations observed in one ancestral group cannot be assumed to generalize directly to another without replication. Differences in linkage disequilibrium—the degree to which adjacent genetic markers are co-inherited—also vary by ancestry, meaning that rs1360787 may track alongside different regulatory variants depending on an individual's genetic background.
What You Can and Cannot Do with This Result
Learning your rs1360787 genotype does not provide a medical diagnosis, nor does it predict whether you will develop any stress-related condition. The evidence linking this variant to clinical outcomes is classified as limited, and genetic factors account for only a small portion of overall mental health. A genotype associated with higher stress sensitivity is neither a guarantee of illness nor a sign of dysfunction; conversely, carrying baseline alleles does not confer immunity to stress or psychological disorders. Consumers should never use personal genomic information to alter medical treatments, discontinue therapies, or adjust the dosage of any prescribed medication. If you have questions about how your genetics may interact with your health or medication regimen, consult a qualified healthcare professional, genetic counselor, or clinical pharmacist for individualized guidance.
How common is this variant?
The minor allele frequency for rs1360787 is approximately 0.30 in European populations, whereas it is lower in East Asian populations at approximately 0.10.
Frequently asked questions
Can rs1360787 diagnose depression or PTSD?
No, rs1360787 is not a diagnostic test for major depression, post-traumatic stress disorder, or any other psychiatric condition. Psychiatric conditions are complex and shaped by hundreds of genetic variants alongside substantial environmental and psychological factors. Clinical diagnoses must always be made by licensed healthcare professionals.
How does FKBP5 influence cortisol in the body?
The FKBP5 gene produces the FKBP51 co-chaperone protein, which binds to glucocorticoid receptors and reduces their sensitivity to cortisol. When FKBP5 levels rise, glucocorticoid receptors are less responsive, which can delay the shutdown of cortisol production through the body's normal negative feedback mechanism.
Does having a risk allele mean I will handle stress poorly?
Not at all. Scientific studies evaluate statistical associations across large cohorts, not individual destiny. Many individuals carrying minor alleles at FKBP5 loci demonstrate robust emotional resilience, particularly in supportive environments.
Should I change my medications based on my FKBP5 genotype?
No, you should never start, stop, or adjust prescription medications based on direct-to-consumer genetic testing results. If you have concerns about your psychiatric care or medication side effects, discuss them directly with your prescribing physician or a pharmacist.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1360787?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FKBP5
This intronic variant in the FKBP5 gene modulates glucocorticoid receptor sensitivity and is linked to altered stress reactivity and susceptibility to psychiatric conditions like PTSD and depression.
Intronic variant in FKBP5; while FKBP5 is a well-established stress-response gene, specific associations for rs4713919 with HPA axis dynamics are less robustly replicated than other variants like rs1360780.
Modulates FKBP5 chaperone expression and alters glucocorticoid receptor sensitivity and negative feedback regulation of the HPA axis.
Functional polymorphism in FKBP5 that modulates ultradian and stress-induced cortisol secretion and alters recovery trajectories following acute psychological stress.
Intronic regulatory variant within FKBP5 linked to altered glucocorticoid receptor sensitivity and acute cortisol response following psychosocial stress.
A well-characterized non-coding FKBP5 tag variant linked with altered cortisol awakening response and susceptibility to stress-induced anxiety disorders.